Expression of insulin-like growth factor-I (IGF-I) in alveolar macrophages and lymphocytes obtained by bronchoalveolar lavage (BAL) in interstitial lung diseases (ILD). Assesment of IGF-I as a potential local mitogen and antiapoptic cytokine

Folia Histochemica et Cytobiologica

Volumn 44, Issue 4, 2006, Pages 249-258

  Kopiński, Piotr ^a   Sładek, Krzysztof ^b   Szczeklik, Jerzy ^b   Soja, Jerzy ^b   Szlubowski, Artur ^b   Balicka Ślusarczyk, Barbara ^b   Lackowska, Bozena ^c   Plato, Marta ^a   Szpechciński, Adam ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Alveolar macrophages; Apoptosis; Asbestosis; Cell cycle; Idiopathic pulmonary fibrosis; Insulin like growth factor I; Lymphocytes; Sarcoidosis; Silicosis

Indexed keywords

CYTOKINE; FAS ANTIGEN; FAS LIGAND; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MITOGENIC AGENT; PROPIDIUM IODIDE; PROTEIN BCL 2; SOMATOMEDIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; ASBESTOSIS; CELL CYCLE; CELL PERMEABILIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; DISEASE SEVERITY; FEMALE; FIBEROSCOPE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SARCOIDOSIS; SILICOSIS; THORAX RADIOGRAPHY;

EID: 33750709280     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Agostini C, Perin A, Semenzato G (1998) Cell apoptosis and granulomatous lung diseases. Curr Opin Pulm Med 4: 261-266
2. Allen JT, Bloor CA, Knight RA, Spiteri MA (1998) Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Am J Respir Cell Mol Biol 19: 250-258
3. BAL Cooperative Steering Comittee (1990) Lymphocyte surface antigen phenotypes in broncholaveolar lavage fluid and peripheral blood. In: Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis and selected comparison groups. Am Rev Respir Dis 141: S169-S202
4. Bingisser R, Stey C, Wellew M, Groscurth P, Russi E, Frei K (1996) Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 15: 64-70
5. Bloor CA, Allen JT, Knight RA (2001) Differential mRNA expression of insulin-like growth factor-I splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 164: 265-272
6. Borges VM, Lopes MF, Flaca H, Leite-Junior JH, Rocco PRM, Davidson WF, Linden R, Zin WA and DosReis GA (2002) Apoptosis underlies immunopathogenic mechanisms in acute silicosis. Am J Respir Cell Mol Biol 27: 78-84
7. Borron P, Veldhuizen RAW, Lewis JF, Possmayer F, Caveney A, Inchley K, McFadden RG, Fraher LJ (1996) Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. Am J Respir Cell Mol Biol 15: 115-121
8. Cambrey AD, Kwon OJ, Gray AJ, Harrison NK, Yacoub M, Barnes PJ, Laurent GJ, Chung KF (1995) Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells. Clin Sci 89: 611-617
9. Chen F, Deng HY, Ding GF, Houng DW, Deng YL, Long ZZ (1994) Excessive production of insulin-like growth factor-I in silicotic rat alveolar macrophages. APMIS 102: 581-588
10. Fujimura N (2000): Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med 6: 140-144
11. Hoser G, Kawiak J, Domagała-Kulawik J, Kopinski P, Droszcz W (1999) Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol 37: 25-30
12. Hunninghake GW, Costabel U, Ando M (1999) ATS/ERS/WASOG statement of sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149-173
13. Klech H, Pohl W (1989) Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Resp J 2: 561-585
14. Kopiński P (1997) Flow cytometry applied in cytological changes assessment in interstitial lung diseases (in Polish). Folia Med Cracov 38: 69-115
15. Kopiński P, Soja J, Czunko P, Jedynak U, Lackowska B, Szczeklik J, Sładek K, Chłap Z (2000) Cytoimmunological alterations in bronchoalveolar lavage (BAL) obtained in non-symptomatic individuals chronically exposed to silica dust (in Polish). Pneumonol Alergol Pol 68: 109-119
16. Krein P, Winston B (2002) Roles of insulin-like growth factor-I and transforming growth factor-β in fibrotic lung disease. Chest 122: 289-293
17. Laflamme C, Israël-Assayag E, Cormier Y (2003) Apoptosis of bronchoalveolar lavage lymphocytes in hypersensitivity pneumonitis. Eur Respir J 21: 225-231
18. Lohman-Matthes ML, Steinmüller C, Franke-Ullman G (1994) Pulmonary macrophages. Eur Respir J 7: 1678-1689
19. McAnulty RJ, Guerreiro D, Cambrey AD, Laurent GJ (1992) Growth factor activity in the lung during compensatory growth after pneumonectomy: evidence of a role for IGF-1. Eur Respir J 5: 739-747
20. Merchant RK, Schwartz DA, Helmers RA, Dayton ChS, Hunninghake GW (1992): Bronchoalveolar lavage cellularity. The distribution in normal volunteers. Am Rev Respir Dis 146: 448-453
21. Mustaers SE, Harrison NK, McAnulty RJ, Liao JY, Laurent GJ, Musk AW (1998) Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta. J Pathol 185: 199-203
22. Pabst R, Binns RM (1996) Lymphocytes migrate from the bronchoalveolar lavage space to regional bronchial lymph nodes. Am J Respir Crit Care Med 151: 495-499
23. Pala L, Giannini S, Rosi E, Cresci B, Scano G, Mohan S, Duranti R, Rotella CM (2001) Direct measurement of IGF-I and IGFBP-3 in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis. J Endocrinol Invest 24: 856-864
24. Pirozyński M, Pirozyńska E (1999) Bronchoalveolar lavage (in Polish). In: Bronchofiberoskopia, Pirozyński M [Ed], α-Medica Press, Bielsko-Biała, pp 118-127
25. Pollak M (2000) Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36: 1224-1228
26. Rom WN, Paakko P (1991) Activated alveolar macrophages express the insulin-like growth factor-I receptor Am J Respir Cell Mol Biol 4: 432-439
27. Rubin R, Baserga R (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 73: 311-331
28. Stridh H, Planck A, Gigliotti D, Eklund A, Grunewald J (2002) Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 57: 897-901
29. Szczeklik J, Trojan J, Kopiński P Soja J, Szlubowski A, Dziedzina S, Iwaniec T, Woś M (2004) Apoptosis in bronchoalveolar lavage lymphocytes (L-BAL) in pneumoconiosis (in Polish). Przegl Lek 61: 235-240
30. Trojan LA, Kopinski P, Wei MX, Ly A, Glogowska A, Czarny J, Shevelev A, Przewlocki R, Henin D, Trojan J (2002): IGF-I: from diagnostic to triple-helix gene therapy of solid tumors. Acta Biochim Pol 49: 979-990
31. Uh ST, Inoue Y, King TE Jr, Chan ED, Newman LS, Riches DW (1998) Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158: 1626-1635
32. Vanhee D, Gosset P, Wallaert B, Voisin C, Tonnel AB (1994) Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am J Respir Crit Care Med 150: 1049-1055